News 2014-09-12
2014 Semi-Annual & OD project summary conference
The conference of 2014 semi-annual and OD project summary was held on Aug. 31st to Sep. 2nd 2014 at Jin Fo Shan in Nanshuan District.
During the meeting, we summarized the progress of “Three Battles (BPM, GMP and KAM)”which were confirmed at the beginning of this year. We also concluded and analyzed the performance of each economic indicator in H1 of 2014.
The redefined core values and its connotations were officially published on Sep. 1st, 2014, and thus determined the concept of Porton culture on its mission, vision and core values.
Others
More
News 2025-01-14
Successful GMP Drug Product Delivery by Porton Biologics and Conjugates Platform
Recently, the Porton Biologics and Conjugates Platform successfully completed the GMP contract manufacturing of three batches of sterile drug products for a client at our R&D and production facility in Pudong, Shanghai. This milestone marks a significant step forward for our Biologics and Conjugates CDMO platform—a testament to our unwavering commitment to quality and reliability.
News 2025-01-03
Porton Achieves Higher Scores in the 2024 S & P Global ESG Assessment
Porton Pharma Solutions Ltd. (hereinafter “Porton”) is glad to announce that it scored 44 (out of 100) in the 2024 S&P Global Corporate Sustainability Assessment reflecting an improvement of 6 points over the previous assessment, where scores in all the three dimensions getting improved. (CSA Score as of 27/11/2024).
